Loading...
EMERGING DRUG PROFILE: Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Dysregulation of the histone methyltransferase EZH2 plays a critical role in the development of a variety of malignancies including B-cell lymphomas. As a result, a series of small molecule inhibitors of EZH2 have been developed and studied in the pre-clinical setting. Three EZH2 inhibitors: tazemet...
Na minha lista:
| Udgivet i: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659997/ https://ncbi.nlm.nih.gov/pubmed/29473431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1430795 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|